Pfizer files for Patent on Known Substance
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether…
190 articles
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether…
The Indian Patent Office has replaced earlier provisions with new Guidelines for Computer Related Inventions, clarifying patentability criteria under section 3k of the Patents Act. The Guidelines provide…
The Indian Patent Office has revoked Roche’s Valganciclovir patent, emphasizing Section 3d and public interest. This decision strengthens access to medicines in India and curbs evergreening by pharmaceutical…
Rajiv Aggarwal has taken charge as the new Controller General of Patents, Designs and Trade Marks, signaling ongoing reform in India’s IP administration. His tenure is expected to…
InPASS, the Indian Patent Advanced Search System, was launched by the Indian Patent Office in February 2015 to provide full-text patent search functionality. This initiative aims to increase…
Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C…
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects…
The Indian Patent Office set aside Abbott Biotechnology's Humira patent after Glenmark's pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges…
This post describes the different types of patent applications available under Indian law and their essential procedural requirements. It provides clarity on the patent process in India, focusing…
The Indian Patent Office has implemented significant upgrades to its electronic patent filing system, incorporating broader e-filing capabilities and changes under the Patents Amendment Rules 2014. These amendments…